Prohibitin 3′ Untranslated Region Polymorphism and Breast Cancer Risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 11 II, 2003, Pages 1273-1274

  Campbell, Ian G ^a   Allen, James ^a   Eccles, Diana M ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROHIBITIN; PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; REPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADOLESCENT; BREAST TUMOR; GENETICS; ONSET AGE; PEDIGREE; RISK; RISK FACTOR;

3' UNTRANSLATED REGIONS; ADOLESCENT; AGE OF ONSET; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; ODDS RATIO; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEINS; REPRESSOR PROTEINS; RISK FACTORS;

EID: 1542438830     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. McClung, J. K., King, R. L., Walker, L. S., Danner, D. B., Nuell, M. J., Stewart, C. A., and Dell'Orco, R. T. Expression of prohibitin, an antiproliferative protein. Exp. Gerontol., 27: 413-417, 1992.
2. Wang, S., Nath, N., Adlam, M., and Chellappan, S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene, 18: 3501-3510, 1999.
3. Sato, T., Saito, H., Swensen, J., Olifant, A., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., Miki, Y., et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52: 1643-1646, 1992.
4. Sato, T., Sakamoto, T., Takita, K., Saito, H., Okui, K., and Nakamura, Y. The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics, 17: 762-764, 1993.
5. Jupe, E. R., Liu, X. T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations. Cell Growth Differ., 7: 871-878, 1996.
6. Jupe, E. R., Badgett, A. A., Neas, B. R., Craft, M. A., Mitchell, D. S., Resta, R., Mulvihill, J. J., Aston, C. E., and Thompson, L. F. Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility. Lancet, 357: 1588-1589, 2001.
7. Spurdle, A. B., Hopper, J. L., Chen, X., McCredie, M. R., Giles, G. G., Newman, B., and Chenevix-Trench, G. Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women. Lancet, 360: 925-926, 2002.
8. Eccles, D., Marlow, A., Royle, G., Collins, A., and Morton, N. E. Genetic epidemiology of early onset breast cancer. J. Med. Genet., 31: 944-949, 1994.
9. Eccles, D. M., Englefield, P., Soulby, M. A., and Campbell, I. G. BRCA1 mutations in southern England. Br. J. Cancer, 77: 2199-2203, 1998.